e-learning
resources
Berlin 2001
Tuesday 25.09.2001
Prognosis and strategy in lung cancer management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer
G. Buccheri, D. Ferrigno (Cuneo, Italy)
Source:
Annual Congress 2001 - Prognosis and strategy in lung cancer management
Session:
Prognosis and strategy in lung cancer management
Session type:
Oral Presentation
Number:
3206
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Buccheri, D. Ferrigno (Cuneo, Italy). Importance of weight loss definition in the prognostic evaluation of nonsmall cell lung cancer. Eur Respir J 2001; 16: Suppl. 31, 3206
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Assessing the relevance of biological prognostic indices in predicting survival in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Prognostic value of smoking status in operated non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 40s
Year: 2004
Prognostic value of apoptotic index in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004
Prognostic value of comorbidity in operated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006
Effect of comorbidity on the prognosis of non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006
Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
Prognostic value of integrated FDG-PET/CT in non-small cell lung cancer
Source: Annual Congress 2008 - New imaging techniques in chest imaging
Year: 2008
Prognostic factors in non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Effects of prognostic factors on survival of the patients of non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005
Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012
Effects of pretreatment prognostic factors and treatment on survival in advanced nonsmall cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 431s
Year: 2003
Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004
Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 136-142
Year: 2011
The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Quantification of telomerase activity is important in predicting prognosis of patients with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 482s
Year: 2005
Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Prognostic factors for non-small cell lung cancer: an analysis of last decade
Source: Eur Respir J 2005; 26: Suppl. 49, 325s
Year: 2005
Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
CHD4 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor cell proliferation
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1357-1364
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept